GGrantIndex
Sort

141,003 grants matching cytokine

Staphylococcus aureus induced itch and neuro-immune signaling in skin infections

$719,259
Isaac Ming-Cheng Chiu · Harvard Medical School · R01 · FY2022 · AI

Inflammasome regulation underlying sexual dimorphism in periodontitis

$719,229
Julie Teresa Marchesan · Univ Of North Carolina Chapel Hill · R01 · FY2023 · DE

Human antibodies for therapeutic intervention of staph enterotoxin B exposure

$719,213
Luigi Grasso · Morphotek, Inc. · U01 · FY2008 · AI

Modified Tetracycline Effect on Sepsis-Induced Mortality

$719,101
Collagenex Pharmaceuticals, Inc. · R42 · FY2005 · HL

Atherogenic Mechanisms of Electronic Nicotine Delivery Systems

$719,085
Sanjay Srivastava · University Of Louisville · R01 · FY2022 · HL

Project 1: Novel Pharmacological Inhibitors of Chemical Vesicants-mediated Cutaneous Injury

$719,082
Mohammad Athar · University Of Alabama At Birmingham · U54 · FY2021 · ES

Project 2: Attenuating Pulmonary Toxicity of Cutaneous Exposure to Arsenicals

$719,079
Aftab Ahmad · University Of Alabama At Birmingham · U54 · FY2021 · ES

Optimizing suprachoroidal AAV delivery in nonhuman primates for retinal gene therapies

$719,012
Glenn Yiu · University Of California At Davis · R01 · FY2025 · EY

Integrated Functional Histopathology of the Diabetic Human Pancreas

$719,000
Matthias G. Von Herrath · La Jolla Institute For Immunology · R01 · FY2018 · AI

Clinical and Translational Investigations of Immune Suppression and Immune Modulation in Glioblastoma

$718,983
Edjah Nduom · National Institute Of Neurological Disorders And Stroke · ZIA · FY2023 · NS

Molecular Phenotypes within and across disease boundaries in IPF and COPD

$718,962
Naftali Kaminski · University Of Pittsburgh At Pittsburgh · R01 · FY2010 · HL

Non-conventional signaling by α5 integrin in blood and endothelial cells

$718,854
Jieqing Zhu · Versiti Wisconsin, Inc. · R01 · FY2024 · HL

Non-conventional signaling by α5 integrin in blood and endothelial cells

$718,854
Jieqing Zhu · Versiti Blood Health, Inc. · R01 · FY2025 · HL

Sputum Microbial Markers of Type 2-Low Asthma

$718,815
Yvonne Jean Huang · University Of Michigan At Ann Arbor · R01 · FY2020 · AI

Predictive Informatics Monitoring in the Neonatal Intensive Care Unit

$718,813
Joseph Randall Moorman · University Of Virginia · R01 · FY2018 · HD

Preclinical Assessment of a Multi-Head Electroporation Device for Delivery of Bio

$718,789
Connie Schmaljohn · Geneva Foundation · R01 · FY2013 · AI

Mechanisms of Meditation

$718,774
Charles L Raison · University Of Arizona · R01 · FY2012 · AT

Effect of IL-21 treatment concurrent to ART and 3HP in Mtb/SIV co-infection

$718,758
Riti Sharan · Texas Biomedical Research Institute · R56 · FY2024 · AI

Toxicant Production and Mitigation in the Electronic-Cigarette Reaction Vessel

$718,706
Robert M Strongin · Portland State University · R01 · FY2018 · ES

Staphylococcal superantigen and anthrax inhibitors

$718,668
Patrick M Schlievert · University Of Chicago · U54 · FY2010 · AI

A novel pathway of Th17/Th2 induction: The role of cAMP signaling in DC

$718,659
Eyal Raz · University Of California, San Diego · R01 · FY2021 · HL

Sociodemographic Disparities in SLE Incidence: Behavioral and Psychosocial Factors

$718,646
Karen H Costenbader · Brigham And Women'S Hospital · R01 · FY2019 · AR

Innate immune response of LTBI+HIV+ children

$718,640
Ramakrishna Vankayalapati · University Of Texas Hlth Ctr At Tyler · R01 · FY2020 · AI

Copper transport protein and inflammatory angiogenesis

$718,635
Tohru Fukai · University Of Illinois At Chicago · R01 · FY2015 · HL

Cellular and Circulating Fortilin in Vascular Diseases

$718,619
Ken Fujise · University Of Washington · R01 · FY2020 · HL